In the present study, we applied this peptide to HCC models and reported that it significantly inhibited YAP activation, PD-L1 expression, and sphere-forming ability, ultimately restoring antitumor immunity and enhancing drug responsiveness. Here, CD274 is linked to hepatocellular carcinoma.